Publications by authors named "Elise Kohn"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

89

Total Likes

388

Extended Reach

652,137

Social Features

201
A
A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era.
Casey M Cosgrove, Dmitriy Zamarin, Jose R Conejo-Garcia, Kari E Hacker, Roberto Vargas, Elise C Kohn

J Natl Cancer Inst· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.
Jung-Min Lee, Austin Miller, Peter G Rose, Mariam AlHilli, Christina Washington, Elise C Kohn

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Diverse Aspects of Uterine Serous Cancer: an NCI workshop on the status of and opportunities for advancement of research.
Naveena B Janakiram, Megan A Clarke, Mihoko Kai, Tiffany A Wallace, Sandra Russo, Elise C Kohn

J Natl Cancer Inst· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
Jennifer A Chan, Susan Geyer, Tyler Zemla, Michael V Knopp, Spencer Behr, Elise C Kohn

N Engl J Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.
Yingmiao Liu, Jiatong Li, Jing Lyu, Lauren E Howard, Alexander B Sibley, Elise C Kohn

Cancer Epidemiol Biomarkers Prev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.
Jung-Min Lee, Mark F Brady, Austin Miller, Richard G Moore, Helen MacKay, Elise C Kohn

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892).
Sarah E Taylor, Sarah Behr, Kristine L Cooper, Haider Mahdi, Denise Fabian, Elise C Kohn

Cancer Chemother Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.
Jalid Sehouli, Jolijn Boer, Alison H Brand, Amit M Oza, Jennifer O'Donnell, Elise C Kohn

Int J Gynecol Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
Joyce F Liu, Niya Xiong, Robert M Wenham, Andrea Wahner-Hendrickson, Deborah K Armstrong, Elise C Kohn

Gynecol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of Adults With Cancer: ASCO Guideline Clinical Insights.
Mini Kamboj, Kari Bohlke, Elise C Kohn

JCO Oncol Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses.
Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, Alexandre André B A da Costa, Doga Gulhan, Elise C Kohn

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top advances of the year: Ovarian cancer.
Melissa A Lumish, Elise C Kohn, William P Tew

Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.
Simron Singh, Thomas A Hope, Emily B Bergsland, Lisa Bodei, David L Bushnell, Elise C Kohn

J Natl Cancer Inst· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update.
William P Tew, Christina Lacchetti, Elise C Kohn,

J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report.
Josee-Lyne Ethier, Katherine C Fuh, Rebecca Arend, Gottfried E Konecny, Panagiotis A Konstantinopoulos, Elise C Kohn

JCO Precis Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Ignace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, Charlie Gourley, Mansoor Raza Mirza, Elise C Kohn

Lancet Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial.
Joyce F Liu, Mark F Brady, Ursula A Matulonis, Austin Miller, Elise C Kohn

J Clin Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Development: Bedside to Bench.
Grace E Mishkin, Elise C Kohn

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020.
Satya Das, Liping Du, Cody L Lee, Nina D Arhin, Jennifer A Chan, Elise C Kohn

JAMA Netw Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer.
Panagiotis A Konstantinopoulos, Alexandre André B A da Costa, Doga Gulhan, Elizabeth K Lee, Su-Chun Cheng, Elise C Kohn

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline.
Verna D Vanderpuye, Jean Rene V Clemenceau, Sarah Temin, Zeba Aziz, William M Burke, Elise C Kohn

JCO Glob Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response.
Linda R Duska, Virginia L Filiaci, Joan L Walker, Laura L Holman, Emily K Hill, Elise C Kohn

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.
David A Wheeler, Naoko Takebe, Toshinori Hinoue, Katherine A Hoadley, Maria F Cardenas, Elise C Kohn

Cancer Cell· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal chemotherapy: Hot, timely, and relevant?
Helen J Mackay, Elise C Kohn

Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis